Skip to content

Takeda Named International Prime Employer for Sixth Consecutive Yr

OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK) at present introduced that, for the sixth consecutive 12 months, it was one in all solely 15 corporations to realize international Prime Employer® certification by 2023. Along with the worldwide certification, Takeda can be acknowledged as a Prime Employer throughout 22 nations, strengthening its dedication to creating a various, equitable and inclusive working surroundings and an distinctive worker expertise.

The Prime Employers Institute program certifies organizations primarily based on the participation and outcomes of their HR Finest Practices Survey. This survey covers six HR domains consisting of 20 matters together with Folks Technique, Work Atmosphere, Expertise Acquisition, Studying, Range & Inclusion, Effectively-being and extra.

We’re steadfast in our dedication to making a tradition that fosters collaboration, well-being and resilience, and this recognition as a world prime employer by the Prime Employers Institute additional underscores that focus,” mentioned Lauren Duprey, chief human assets officer, Takeda. “The work we do transforms lives, serving to sufferers around the globe with little to no therapy choices, and our individuals are on the cornerstone of all the pieces we accomplish. Our folks do enterprise with a objective and we’re proud to supply them a piece surroundings that allows their success.”

Distinctive instances deliver out one of the best in folks and organizations, and now we have witnessed this in our Prime Employers Certification Program this 12 months: an distinctive efficiency from the licensed Prime Employers 2023. Amongst this group of excellent organizations, Takeda, has confirmed its dedication to its workers on a world scale,” mentioned David Plink, chief govt officer, Prime Employers Institute. “This consistency in folks practices throughout the globe characterizes an unique group of corporations which have achieved a world certification by means of the Prime Employers Program. We’re proud to announce and have a good time these corporations and their achievement in 2023.”

Takeda excelled globally within the areas of Ethics & Integrity, Function & Values, Enterprise Technique, Employer Branding and Group & Change. Every of the 22 Takeda nations and areas that participated within the Prime Employer survey obtained certification, together with Canada for the primary time. The complete listing of nations the place Takeda was named a Prime Employer is under:

  • Asia Pacific: Australia, China, India, Japan, South Korea
  • Europe: Austria, France, Germany, Eire, Italy, Poland, Portugal, Spain, Switzerland, United Kingdom.
  • Latin America: Argentina, Brazil, Colombia, Mexico
  • Center East: Israel
  • North America: Canada and United States

To be taught extra about Prime Employers Institute and the Prime Employers certification, please go to:

About Takeda

Takeda is a world, values-based, R&D-driven biopharmaceutical chief headquartered in Japan, dedicated to discovering and delivering life-transforming therapies, guided by our dedication to sufferers, our folks and the planet. Takeda focuses its R&D efforts on 4 therapeutic areas: Oncology, Uncommon Genetics and Hematology, Neuroscience, and Gastroenterology (GI), with experience in immune and inflammatory illnesses. We additionally make focused R&D investments in Plasma-Derived Therapies and Vaccines. We’re specializing in creating extremely modern medicines that contribute to creating a distinction in folks’s lives by advancing the frontier of latest therapy choices and leveraging our enhanced collaborative R&D engine and capabilities to create a strong, modality-diverse pipeline. Our workers are dedicated to bettering high quality of life for sufferers and to working with our companions in well being care in roughly 80 nations and areas. For extra data, go to

Necessary Discover

For the needs of this discover, “press launch” means this doc, any oral presentation, any query and reply session and any written or oral materials mentioned or distributed by Takeda Pharmaceutical Firm Restricted (“Takeda”) relating to this launch. This press launch (together with any oral briefing and any question-and-answer in reference to it) shouldn’t be supposed to, and doesn’t represent, characterize or type a part of any supply, invitation or solicitation of any supply to buy, in any other case purchase, subscribe for, trade, promote or in any other case eliminate, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or different securities are being supplied to the general public by way of this press launch. No providing of securities shall be made in the USA besides pursuant to registration below the US Securities Act of 1933, as amended, or an exemption therefrom. This press launch is being given (along with any additional data which can be supplied to the recipient) on the situation that it’s to be used by the recipient for data functions solely (and never for the analysis of any funding, acquisition, disposal or every other transaction). Any failure to adjust to these restrictions might represent a violation of relevant securities legal guidelines.

The businesses during which Takeda straight and not directly owns investments are separate entities. On this press launch, “Takeda” is usually used for comfort the place references are made to Takeda and its subsidiaries usually. Likewise, the phrases “we”, “us” and “our” are additionally used to seek advice from subsidiaries usually or to those that work for them. These expressions are additionally used the place no helpful objective is served by figuring out the actual firm or corporations.

Leave a Reply

Your email address will not be published. Required fields are marked *